Corcept presents survival data for Lifyorli in ovarian cancer at ASCO
Go back to Corcept presents survival data for Lifyorli in ovarian cancer at ASCO| Corcept Therapeutics, Inc. (NASDAQ: CORT) | Delayed: 83.25 +5.13 (6.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $78.12 | 52 Week High | $10.00 | |||
| Open | $79.01 | 52 Week Low | $3.22 | |||
| Day High | $84.17 | P/E | N/A | |||
| Day Low | $78.50 | EPS | $-0.46 | |||
| Volume | 1,093,880 | |||||
